MVF Stock Overview
Provides assisted reproductive and specialist women imaging services in Australia and Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Monash IVF Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.24 |
| 52 Week High | AU$1.53 |
| 52 Week Low | AU$1.11 |
| Beta | 1.42 |
| 1 Month Change | 8.33% |
| 3 Month Change | 5.56% |
| 1 Year Change | -7.49% |
| 3 Year Change | 15.96% |
| 5 Year Change | 18.75% |
| Change since IPO | -35.17% |
Recent News & Updates
Recent updates
Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025
Aug 25
Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025
Feb 26Monash IVF Group (ASX:MVF) Will Pay A Dividend Of A$0.022
Aug 28Here's What's Concerning About Monash IVF Group's (ASX:MVF) Returns On Capital
Nov 19Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation
Nov 04Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's
Aug 29Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital
May 14Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?
Jun 06Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital
May 25Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value
May 13Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?
Mar 14Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend
Mar 04Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates
Feb 26Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?
Feb 15A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)
Feb 03
We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings
Jan 22Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?
Jan 10Is Monash IVF Group (ASX:MVF) Using Too Much Debt?
Dec 28What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?
Dec 17Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares
Dec 06Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?
Nov 24Shareholder Returns
| MVF | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | -1.2% | -3.1% | -2.0% |
| 1Y | -7.5% | -6.6% | 7.8% |
Return vs Industry: MVF matched the Australian Healthcare industry which returned -6.6% over the past year.
Return vs Market: MVF underperformed the Australian Market which returned 7.8% over the past year.
Price Volatility
| MVF volatility | |
|---|---|
| MVF Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.8% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: MVF has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: MVF's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2024 | 997 | Michael Knaap | www.monashivfgroup.com.au |
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services.
Monash IVF Group Limited Fundamentals Summary
| MVF fundamental statistics | |
|---|---|
| Market cap | AU$475.35m |
| Earnings (TTM) | -AU$6.53m |
| Revenue (TTM) | AU$255.23m |
1.9x
P/S Ratio-73.7x
P/E RatioIs MVF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MVF income statement (TTM) | |
|---|---|
| Revenue | AU$255.23m |
| Cost of Revenue | AU$169.46m |
| Gross Profit | AU$85.77m |
| Other Expenses | AU$92.29m |
| Earnings | -AU$6.53m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.017 |
| Gross Margin | 33.60% |
| Net Profit Margin | -2.56% |
| Debt/Equity Ratio | 24.1% |
How did MVF perform over the long term?
See historical performance and comparisonDividends
4.0%
Current Dividend Yield-298%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 15:22 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Monash IVF Group Limited is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | APP Securities Pty Ltd. |
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Martyn Jacobs | Bell Potter |